California Dermatology & Clinical Research Institute — Encinitas, California

California Dermatology & Clinical Research Institute is a clinical research site located in Encinitas, California, United States 92024.

Crixeo Clinical Trials Trust Score: 28/100 (FAILING). This profile has not yet been claimed by the site owner.

California Dermatology & Clinical Research Institute has participated in 63 clinical trials with 12 currently active.

Therapeutic areas: Alopecia Areata, Atopic Dermatitis, Hyperhidrosis.

Sponsors: Concert Pharmaceuticals, Pfizer, Journey Medical Corporation.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Encinitas

Browse all research sites in California · View every site in Encinitas

Sponsor Feasibility Report

Trust Score: 28/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for California Dermatology & Clinical Research Institute?

California Dermatology & Clinical Research Institute has a Crixeo Trust Score of 28/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has California Dermatology & Clinical Research Institute conducted?

California Dermatology & Clinical Research Institute has 63 clinical trials on record, with 12 currently active. Their work covers Alopecia Areata, Atopic Dermatitis, Hyperhidrosis.

Is California Dermatology & Clinical Research Institute accredited by Crixeo Clinical Trials?

California Dermatology & Clinical Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about California Dermatology & Clinical Research Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.